Cerus Corporation (NASDAQ:CERS) traded at $6.51 at last check on Monday, Jun 29, making a downturn move of -5.03% on its previous day’s price.
Looking at the stock we see that its previous close was $6.86 and the beta (5Y monthly) reads 1.29 with the day’s price range being $6.37 – 6.90. In terms of its 52-week price range, CERS has a high of $7.17 and a low of $2.71. The company’s stock has gained about 4.74% over that past 30 days.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $25.89 Million, with a low of $25.25 Million and a high of $27.3 Million. The median projection represents growth adding up to 15.2% compared to sales earnings for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecasts for 2020 are expected to hit $112.72 Million, or +20.2% up from figures reported last year.
On the other hand, looking at the outlook for the CERS stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Let’s briefly compare Cerus (CERS) stock to its peers. We find that today’s price change of -5.03% and +15.93% over the past 12 months for CERS competes that of Abbott Laboratories (ABT), which has seen its stock price rise 0.34% in the latest trading session and is +5.84% over the last one year. Another of its peers Medtronic Inc (MDT) has climbed 1.68% today, but is -7.32% down over the past year, while Stryker Corp (SYK) is also down -5.03% yet its price remains in the green at 15.93% over the same period. Abbott has a P/E ratio of 44.66 compared to Cerus’ 0 and Medtronic’s 25.63. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 2.32% and 1.47%, respectively, in early deals.
Coming back to Cerus Corporation (NASDAQ:CERS), we note that the average 3-month trading volume was 2.01 Million, while that of the preceding 10-day period stands at 2.49 Million. Current shares outstanding are 163.99 Million.
According to data from Thomson Reuters, insiders hold 2.12% of the company’s shares while institutions hold 66.1%. The data shows that short shares as of June 14, 2020, stood at 9.04 Million at a short ratio of 4.5. This represents a 5.51% Short interest in Shares outstanding on June 14, 2020. Shares short rose in June from the previous month at 8.64 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock +54.38% up in year-to-date price movement.